ISPE Launches “Industry Transformation: The Next Generation of Operational Excellence” Conference
(Brussels, Belgium ) - ISPE announced today its European conference "Industry Transformation: The Next Generation of Operational Excellence" which will take place in Berlin, Germany, on 17 - 18 October 2013. The event will feature two days of intensive education on the new OpEx paradigm in the pharmaceutical industry.
Influential industry experts and regulatory professionals will cover a variety of topics in two parallel tracks exploring four thematic modules: Project Lifecycle, Change Management and Leadership Skills, Process Development and Technology Transfer, and Expanding Operational Excellence Principles within the Manufacturing Networks. These will include an examination of strategic and operational approaches to achieving Operational Excellence.
"The pharmaceutical industry needs to embrace Operational Excellence beyond traditional approaches within individual projects and sites into a cultural transformation, stimulating new ways of meeting the needs of our customers and yet meeting the needs of our stakeholders. While some companies have been successful in their deployment, there are still many organisations that have not realised the benefits. I am convinced that this conference is going to be very relevant for industry professionals who will have the possibility to really look for new ideas and to improve the way they do their work" said Robert Lechich Conference Chair, Director Operational Excellence, Pfizer Global Supply.
The conference will also feature in-depth discussions about the key challenges the pharmaceutical industry is facing today such as drug shortages, the time required to bring products to market, how to achieve regulatory compliance, and the need for continuous improvement within the manufacturing and project environment.
For more information on this conference, including detailed agendas and registration information, visit: www.ISPE.org/2013-Operational-Excellence-EU-Conference
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China.